References
- Barillot I, Horiot JC, Maingon P (1994). Maximum and mean bladder dose defined from ultrasonography. Comparison with the ICRU reference in gynaecological brachytherapy. Radiother Oncol, 30, 231-8. https://doi.org/10.1016/0167-8140(94)90463-4
- Deshpande DD, Shrivastavb SK, Pradhanc AS, et al (1997). Dosimetry of intracavitary applications in carcinoma of the cervix: rectal dose analysis. Radiother Oncol, 42, 163-6. https://doi.org/10.1016/S0167-8140(96)01841-5
- Eifel PJ, Levenback C, Wharton JT, et al (1995). Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys, 32, 1289-300. https://doi.org/10.1016/0360-3016(95)00118-I
- Fellner C, Potter R, Knocke TK, et al (2001). Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol, 58, 53-62. https://doi.org/10.1016/S0167-8140(00)00282-6
- Georg P, Lang S, Dimopoulos JC, et al (2011). Dose volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer bracytherapy. Int J Radiat Oncol Biol Phys, 79, 356-62. https://doi.org/10.1016/j.ijrobp.2009.11.002
- Cheng JC, Peng LC, Chen YH, et al (2003). Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy. Int J Radiat Oncol Biol Phys, 57, 1010-8. https://doi.org/10.1016/S0360-3016(03)00721-1
- Kang HC, Shin KH, Park SY, et al (2010). 33D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control. Radiother Oncol, 97, 507-13. https://doi.org/10.1016/j.radonc.2010.10.002
- Kim RY, Shen S, Duan J (2007). Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel. Brachyther, 6, 187-94. https://doi.org/10.1016/j.brachy.2006.11.005
- Kirisits C, Potter R, Lang S, et al (2005). Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys, 62, 901-11. https://doi.org/10.1016/j.ijrobp.2005.02.040
- Koom WS, Sohn DK, Kim JY, et al (2007).Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy. Int J Radiat Oncol Biol Phys, 68, 1446-54. https://doi.org/10.1016/j.ijrobp.2007.02.009
- Lee LJ, Viswanathan AN (2012). Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer. Int J Radiat Oncol Biol Phys, 84, 1192-7. https://doi.org/10.1016/j.ijrobp.2012.01.085
- Lin Y, Yin LV (2012). Possible risk factors associated with radiation proctitis or radiation cystitis in patients with cervical carcinoma after radiotherapy. Asian Pac J Cancer Prev, 13, 6251-5. https://doi.org/10.7314/APJCP.2012.13.12.6251
- Ling CC, Schell CS, Working KR, et al (1987).CT-assisted assessment of bladder and rectum dose in gynecological implants, Int J Radiat Oncol Biol Phys, 13, 1577-82. https://doi.org/10.1016/0360-3016(87)90327-0
- Mahantshetty U, Tiwana MS, Jamema S,et al (2008). Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study. Brachytherapy, 7, 149.
- Nag S, Beth E, Thomadsen B, et al (2000). The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys, 48, 201-11.
- Pelloski CE, Palmer M, Chronowski GM, et al (2005). Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys, 62, 131-7. https://doi.org/10.1016/j.ijrobp.2004.09.059
- Perez C, Grigsby PW, Lockett MA, et al (1999). Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys, 44, 855-66. https://doi.org/10.1016/S0360-3016(99)00111-X
- Pesee M, Krusun S, Padoongcharoen P (2010), High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications. Asian Pac J Cancer Prev, 11, 491-4.
- Potter R, Haei-Meder C, Limbergen EV, et al (2006). Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol, 78, 67-77. https://doi.org/10.1016/j.radonc.2005.11.014
- Schoeppel SL, LaVigne ML, Martel MK, et al (1993). Three-dimensional treatment planning of intracavitary gynecologic implants: analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys, 28, 277-83.
- Takenada T, Yoshida K, Tachiri S, et al (2012). Comparison of dose-volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer. J Radiat Res, 53, 791-7. https://doi.org/10.1093/jrr/rrs033
- Tan LT (2011). Implementation of image-guided brachytherapy for cervix cancer in the UK: progress update. Clin Oncol, 23, 681-4. https://doi.org/10.1016/j.clon.2011.07.011
- Tan LT, Coles CE, Hart C, Tait E (2009). Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience. Clin Oncol, 21, 175-82. https://doi.org/10.1016/j.clon.2008.12.001
- van den Bergh F, Meertens H, Moonen L, van Bunningen B, Blom A (1998). The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol, 47, 85-90. https://doi.org/10.1016/S0167-8140(97)00187-4
- Vinod SK, Caldwell K, Lau A, Fowler AR (2011). A comparison of ICRU point doses and volumetric doses of organs at risk (OARs) in brachytherapy for cervical cancer. J Med Imaging Radiat Oncol, 55, 304-10. https://doi.org/10.1111/j.1754-9485.2011.02272.x
- Viswanathan AN, Beriwal S, De Los Santos JF, et al (2012). American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy, 11, 33-46. https://doi.org/10.1016/j.brachy.2011.07.003
- Viswanathan AN, Moughan J, Small W Jr, et al (2012). The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer, 22, 123. https://doi.org/10.1097/IGC.0b013e31823ae3c9
- Wachter-Gerstner N, Wachter S, Reinstadler E, et al (2003). Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point. Radiother Oncol, 68, 269-76. https://doi.org/10.1016/S0167-8140(03)00189-0
Cited by
- High Dose Rate Brachytherapy in Two 9 Gy Fractions in the Treatment of Locally Advanced Cervical Cancer - a South Indian Institutional Experience vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.7167
- Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer vol.11, pp.9, 2016, https://doi.org/10.1371/journal.pone.0161932
- Dosimetric evaluation of tandem-based cervical high-dose-rate brachytherapy treatment planning using American Brachytherapy Society 2011 recommendations vol.15, pp.03, 2016, https://doi.org/10.1017/S1460396916000133
- Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer? vol.33, pp.18, 2018, https://doi.org/10.3346/jkms.2018.33.e135